Table 1 Number of clinicopathologic feature in patients.
Clinicopathologic feature | Total | Distant metastasis | ||||
|---|---|---|---|---|---|---|
Yes | No | |||||
1118 | 106 | 9.48% | 1012 | 90.52% | ||
Sex | ||||||
Male | 415 | 37.12% | 64 | 15.42% | 351 | 84.58% |
Female | 437 | 39.09% | 42 | 9.61% | 395 | 90.39% |
Age | ||||||
< 40 | 38 | 3.40% | 7 | 18.42% | 31 | 81.58% |
40–59 | 437 | 39.09% | 39 | 8.92% | 398 | 91.08% |
60–79 | 609 | 54.47% | 54 | 8.87% | 555 | 91.13% |
>=80 | 34 | 3.04% | 6 | 17.65% | 28 | 82.35% |
Length of stay | ||||||
< 15d | 91 | 8.14% | 5 | 5.49% | 86 | 94.51% |
16-25d | 692 | 61.90% | 69 | 9.97% | 623 | 90.03% |
26-35d | 269 | 24.06% | 25 | 9.29% | 244 | 90.71% |
> 35d | 66 | 5.90% | 7 | 10.61% | 59 | 89.39% |
BMI | ||||||
Slim | 66 | 5.90% | 6 | 9.09% | 60 | 90.91% |
Normal | 538 | 48.12% | 54 | 10.04% | 484 | 89.96% |
Overweight | 389 | 34.79% | 37 | 9.51% | 352 | 90.49% |
Fat | 125 | 11.18% | 9 | 7.20% | 116 | 92.80% |
Preoperative chemoradiotherapy | ||||||
No | 1018 | 91.06% | 94 | 9.23% | 924 | 90.77% |
Yes | 39 | 3.49% | 5 | 12.82% | 34 | 87.18% |
Both | 61 | 5.46% | 7 | 11.48% | 54 | 88.52% |
T | ||||||
T0 | 151 | 13.51% | 17 | 11.26% | 134 | 88.74% |
T1 | 9 | 0.81% | 1 | 11.11% | 8 | 88.89% |
T2 | 135 | 12.08% | 8 | 5.93% | 127 | 94.07% |
T3 | 774 | 69.23% | 72 | 9.30% | 702 | 90.70% |
T4 | 49 | 0.0438 | 8 | 0.1633 | 41 | 0.8367 |
N | ||||||
Yes | 409 | 0.3658 | 68 | 0.1663 | 341 | 0.8337 |
No | 709 | 0.6342 | 38 | 0.0536 | 671 | 0.9464 |
Location | ||||||
High | 383 | 0.3426 | 37 | 0.0966 | 346 | 0.9034 |
Medium | 468 | 0.4183 | 37 | 0.0791 | 431 | 0.9209 |
Low | 267 | 0.2388 | 32 | 0.1199 | 235 | 0.8802 |
Hemoglobin (reduce) | ||||||
Yes | 202 | 18.07% | 86 | 42.57% | 116 | 57.43% |
No | 916 | 81.93% | 103 | 11.24% | 813 | 88.76% |
Neutrophilic granulocyte percentage(elevated) | ||||||
Yes | 83 | 7.42% | 6 | 7.23% | 77 | 92.77% |
No | 1035 | 92.58% | 100 | 9.66% | 1029 | 99.42% |
CEA | ||||||
Yes | 402 | 35.96% | 69 | 17.16% | 333 | 82.84% |
No | 716 | 64.04% | 37 | 5.17% | 679 | 94.83% |
CA199 | ||||||
Yes | 999 | 89.36% | 97 | 9.71% | 902 | 90.29% |
No | 119 | 10.64% | 9 | 7.56% | 110 | 92.44% |
Duration of surgery | ||||||
> 3 h | 789 | 70.57% | 55 | 6.97% | 734 | 93.03% |
< 3 h | 320 | 28.62% | 51 | 15.94% | 269 | 84.06% |
Length of bowel resection | ||||||
< 10 cm | 263 | 23.52% | 26 | 9.89% | 237 | 90.11% |
10–15 cm | 607 | 54.29% | 51 | 8.40% | 556 | 91.60% |
> 15 cm | 248 | 22.18% | 29 | 11.69% | 219 | 88.31% |
Distance of margin from the lower border | ||||||
< 1 cm | 153 | 13.69% | 10 | 6.54% | 143 | 93.46% |
1–2 cm | 425 | 38.01% | 37 | 8.71% | 388 | 91.29% |
2–5 cm | 477 | 42.67% | 55 | 11.53% | 422 | 88.47% |
> 5 cm | 63 | 5.64% | 4 | 6.35% | 59 | 93.65% |
Distance of superior incisal margin | ||||||
< 10 cm | 959 | 85.78% | 88 | 9.18% | 871 | 90.82% |
10–15 cm | 135 | 12.08% | 17 | 12.59% | 118 | 87.41% |
> 15 cm | 24 | 2.15% | 1 | 4.17% | 23 | 95.83% |
T pathological | ||||||
T0 | 839 | 75.04% | 60 | 7.15% | 779 | 92.85% |
T1 | 64 | 5.72% | 5 | 7.81% | 59 | 92.19% |
T1 | 180 | 16.10% | 6 | 3.33% | 174 | 96.67% |
T3 | 35 | 3.13% | 35 | 100.00% | 0 | 0.00% |
N pathological | ||||||
N0 | 638 | 57.07% | 66 | 10.34% | 572 | 89.66% |
N1 | 243 | 21.74% | 17 | 7.00% | 226 | 93.00% |
N2 | 237 | 21.20% | 23 | 9.70% | 214 | 90.30% |
Diameter of tumor | ||||||
< 2 cm | 195 | 17.44% | 25 | 12.82% | 170 | 87.18% |
2–5 cm | 676 | 60.47% | 69 | 10.21% | 607 | 89.79% |
> 5 cm | 247 | 22.09% | 12 | 4.86% | 235 | 95.14% |
Lymph node | ||||||
< 12 | 309 | 27.64% | 33 | 10.68% | 276 | 89.32% |
13–22 | 608 | 54.38% | 60 | 9.87% | 548 | 90.13% |
23–32 | 149 | 13.33% | 9 | 6.04% | 140 | 93.96% |
> 32 | 52 | 4.65% | 4 | 7.69% | 48 | 92.31% |
